Phase II, Open Label Adaptive Design Dose Finding Study to Investigate Effect of Synthetic PreImplantation Factor (sPIF) in Patients With High Panel Reactive Antibodies
Status: Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2019
Price : $35 *
At a glance
- Drugs Preimplantation factor (Primary)
- Indications Autoimmune disorders
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 31 Dec 2018 Planned End Date changed from 31 Dec 2018 to 31 Dec 2020.
- 31 Dec 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2020.
- 31 Dec 2018 Planned initiation date changed from 1 Oct 2018 to 1 Feb 2019.